Product Information

THEOPHYLLINE ER 300 MG TABLET is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.3409 per EA under NDC 60219204501. Its NADAC has been published 154 times since Dec 6, 2023.

FDA first approved this application on Mar 20, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

THEOPHYLLINE ER 300 MG TABLET

theophylline
$0.3409per EA

Strength

300 mg/1

NDC

60219204501

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

THEOPHYLLINE ANHYDROUS

Approval Type

Generic (ANDA)

FDA Application

ANDA216276

FDA Approved

3/20/2023

TE Code

AB

On Market Since

3/27/2023

Pharmacological Classes

Price Statistics

The NADAC for THEOPHYLLINE ER 300 MG TABLET has been published 154 times since Dec 6, 2023, and over the history we have for it it has declined 79.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3409 per EA
All-time high$1.8931 (Jan 10, 2024)
All-time low$0.3196 (May 20, 2026)
52-week high$0.4414
52-week low$0.3196
Median price$0.5744
Average price$0.7381
Largest weekly change+88.5% (Aug 21, 2024)
Weeks tracked154
Tracking sinceDec 6, 2023

Price History

1W

0.0%

1M

+3.5%

3M

+5.1%

6M

-1.4%

1Y

-23.6%

3Y

N/A

5Y

N/A

All

-79.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the theophylline market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of THEOPHYLLINE ER 300 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for THEOPHYLLINE ER 300 MG TABLET, manufactured by Amneal Pharmaceuticals NY LLC, is $0.3409 per EA (NDC 60219204501), effective Nov 11, 2026.

How has the price of THEOPHYLLINE ER 300 MG TABLET changed over time?

Over the history we have for it, the NADAC for THEOPHYLLINE ER 300 MG TABLET has declined 79.9%. It has been tracked across 154 weekly CMS publications since Dec 6, 2023.

What are the highest and lowest recorded NADAC prices for THEOPHYLLINE ER 300 MG TABLET?

Since Dec 6, 2023, the NADAC for THEOPHYLLINE ER 300 MG TABLET has ranged from a low of $0.3196 (May 20, 2026) to a high of $1.8931 (Jan 10, 2024), with a median of $0.5744 per EA.

Are there cheaper alternatives to THEOPHYLLINE ER 300 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of THEOPHYLLINE ER 300 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures THEOPHYLLINE ER 300 MG TABLET?

THEOPHYLLINE ER 300 MG TABLET (NDC 60219204501) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.